首页 > 最新文献

International Journal of Endocrinology and Metabolism最新文献

英文 中文
A Systematic Review and Meta-analysis of Diabetes Associated Mortality in Patients with COVID-19. COVID-19患者糖尿病相关死亡率的系统评价和荟萃分析
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2021-09-15 eCollection Date: 2021-10-01 DOI: 10.5812/ijem.113220
Puneeta Gupta, Meeta Gupta, Neena KAtoch, Ketan Garg, Bhawna Garg

Context: Coronavirus disease 2019 (COVID-19) has been one of the deadliest pandemics in recent decade. The virus has specifically targeted the comorbid population in terms of mortality. The present systematic review and meta-analysis aimed to determine the overall mortality and diabetes-associated mortality in COVID-19 patients.

Methods: To obtain the related data, six databases, including Pubmed, Embase, MEDLINE, Web of Science, Google Scholar, and DOAJ, were searched. The full-texts of articles presenting the data of COVID-19 mortality and diabetes-associated mortality were screened and retrieved. Statistical analysis was performed using the Stata (version 13). The odds ratio (OR) of mortality in diabetic patients was calculated with 95% confidence interval (CI). Random-effects model was used to synthesize data for the relevant outcomes. Heterogeneity was evaluated using I2 statistic. Forest plots visually showed the effect estimates of the included studies. We used funnel plots to evaluate potential publication bias. A two tailed P < 0.05 was considered as statistically significant.

Results: A total of 35 studies with 25,934 patients were finally included for meta-analysis. The pooled prevalence of diabetes mellitus in patients with COVID-19 was 16.8% (n = 4381). The overall mortality seen in all the studies was 12.81% (n = 3159), and diabetes-associated mortality was 22.14% (n = 970). The pooled analysis of included studies showed that diabetes mellitus had a significantly higher mortality rate (22.14% vs. 12.81%, P < 0.05) with higher odds of death (pooled OR 1.83, 95% CI: 1.61 - 2.05). The funnel plot was symmetric, thereby indicating a low risk of publication bias.

Conclusions: In conclusion, the presence of diabetes was associated with a significantly increased risk of mortality in patients admitted to the hospital with COVID-19. Thus, this subpopulation must be continuously monitored for glycemic levels, coagulation abnormalities, and inflammatory surge.

背景:2019冠状病毒病(新冠肺炎)是近十年来最致命的流行病之一。该病毒在死亡率方面专门针对共病人群。本系统综述和荟萃分析旨在确定新冠肺炎患者的总体死亡率和糖尿病相关死亡率。方法:检索Pubmed、Embase、MEDLINE、Web of Science、Google Scholar和DOAJ六个数据库,获取相关数据。对提供新冠肺炎死亡率和糖尿病相关死亡率数据的文章全文进行筛选和检索。使用Stata(版本13)进行统计分析。糖尿病患者死亡率的比值比(OR)采用95%置信区间(CI)计算。随机效应模型用于综合相关结果的数据。使用I2统计量评估异质性。森林图直观地显示了纳入研究的效果估计。我们使用漏斗图来评估潜在的发表偏倚。双尾P<0.05被认为具有统计学意义。结果:共有35项研究,25934名患者最终纳入荟萃分析。新冠肺炎患者糖尿病合并患病率为16.8%(n=4381)。所有研究的总死亡率为12.81%(n=3159),糖尿病相关死亡率为22.14%(n=970)。纳入研究的汇总分析显示,糖尿病的死亡率显著较高(22.14%对12.81%,P<0.05),死亡率较高(合并OR 1.83,95%CI:1.61-2.05)。漏斗图是对称的,因此表明发表偏倚的风险较低。结论:总之,糖尿病的存在与新冠肺炎住院患者的死亡率显著增加有关。因此,必须持续监测该亚群的血糖水平、凝血异常和炎症激增。
{"title":"A Systematic Review and Meta-analysis of Diabetes Associated Mortality in Patients with COVID-19.","authors":"Puneeta Gupta, Meeta Gupta, Neena KAtoch, Ketan Garg, Bhawna Garg","doi":"10.5812/ijem.113220","DOIUrl":"10.5812/ijem.113220","url":null,"abstract":"<p><strong>Context: </strong>Coronavirus disease 2019 (COVID-19) has been one of the deadliest pandemics in recent decade. The virus has specifically targeted the comorbid population in terms of mortality. The present systematic review and meta-analysis aimed to determine the overall mortality and diabetes-associated mortality in COVID-19 patients.</p><p><strong>Methods: </strong>To obtain the related data, six databases, including Pubmed, Embase, MEDLINE, Web of Science, Google Scholar, and DOAJ, were searched. The full-texts of articles presenting the data of COVID-19 mortality and diabetes-associated mortality were screened and retrieved. Statistical analysis was performed using the Stata (version 13). The odds ratio (OR) of mortality in diabetic patients was calculated with 95% confidence interval (CI). Random-effects model was used to synthesize data for the relevant outcomes. Heterogeneity was evaluated using I2 statistic. Forest plots visually showed the effect estimates of the included studies. We used funnel plots to evaluate potential publication bias. A two tailed P < 0.05 was considered as statistically significant.</p><p><strong>Results: </strong>A total of 35 studies with 25,934 patients were finally included for meta-analysis. The pooled prevalence of diabetes mellitus in patients with COVID-19 was 16.8% (n = 4381). The overall mortality seen in all the studies was 12.81% (n = 3159), and diabetes-associated mortality was 22.14% (n = 970). The pooled analysis of included studies showed that diabetes mellitus had a significantly higher mortality rate (22.14% vs. 12.81%, P < 0.05) with higher odds of death (pooled OR 1.83, 95% CI: 1.61 - 2.05). The funnel plot was symmetric, thereby indicating a low risk of publication bias.</p><p><strong>Conclusions: </strong>In conclusion, the presence of diabetes was associated with a significantly increased risk of mortality in patients admitted to the hospital with COVID-19. Thus, this subpopulation must be continuously monitored for glycemic levels, coagulation abnormalities, and inflammatory surge.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/56/a2/ijem-19-4-113220.PMC8762284.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39852408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal Emotional States in Relation to Offspring Weight and Health-Related Quality of Life: Tehran Lipid and Glucose Study. 母亲情绪状态与后代体重和健康相关生活质量的关系:德黑兰脂质和葡萄糖研究
IF 2.1 Q3 Medicine Pub Date : 2021-09-12 eCollection Date: 2021-10-01 DOI: 10.5812/ijem.113107
Parnian Parvin, Parisa Amiri, Sara Jalali-Farahani, Mehrdad Karimi, Mina Moein Eslam, Fereidoun Azizi

Background: Maternal characteristics have been known to be associated with parenting practices, which could eventually influence their child's weight and health-related quality of life (HRQoL).

Objectives: This study aimed to assess the direct and indirect associations of maternal emotional states (depression, anxiety, and stress) with body mass index (BMI) and HRQoL in their children.

Methods: This study was conducted within the framework of the Tehran lipid and glucose study (TLGS). Participants were the children (n = 231) enrolled in TLGS during 2014 - 2016, who had complete data on maternal emotional states. The body weight and height of children were measured using the standard protocol, and BMI Z-score was determined using Anthroplus. Also, HRQoL in children and emotional states in mothers were assessed using the Iranian version of the pediatric quality of life inventory (PedsQLTM4.0) and the depression, anxiety, and stress scale (DASS-21), respectively. Structural equations modeling (SEM) was used to assess the direct and indirect relations of maternal emotional states with children's BMI Z-score and HRQoL.

Results: Mean age, BMI Z-score, and HRQoL total score in children were 13.8 ± 3.1 years, 0.74 ± 1.5, and 84.7 ± 11.3, respectively. In the mothers, median DASS-21 scores (interquartile ranges) in the three scales of depression, anxiety, and stress were 4 (0 - 10), 6 (2 - 12), and 14 (8 - 20), respectively. Maternal level of education was significantly associated with the DASS-21 score (β = -0.23, 95% CI: -0.37,-0.07). Maternal DASS-21 score was significantly associated with BMI Z-score only in girls (β = 0.25, 95% CI: 0.06, 0.53). Significant determinants of HRQoL in boys were the child's age (β = -0.21, 95% CI: -0.40, -0.01) and maternal education (β = -0.24, 95%CI: -0.44, -0.02) and emotional state (β = -0.24, 95% CI: -0.44, -0.03). The child's age (β = -0.33, 95% CI: -0.53, -0.10) and maternal emotional state (β = -0.31, 95% CI: -0.54, -0.08) were significantly associated with HRQoL in girls.

Conclusions: The maternal emotional state is an important determinant of HRQoL in children, regardless of their weight status. Further research is recommended to examine the current hypothesized model in rural and suburban populations, taking into consideration more influential factors.

背景:众所周知,母亲的特征与养育方式有关,这可能最终影响孩子的体重和健康相关的生活质量(HRQoL)。目的:本研究旨在评估母亲情绪状态(抑郁、焦虑和压力)与其子女身体质量指数(BMI)和HRQoL的直接和间接关联。方法:本研究在德黑兰脂质和葡萄糖研究(TLGS)的框架内进行。参与者是2014 - 2016年期间参加TLGS的儿童(n = 231),他们有完整的母亲情绪状态数据。采用标准方案测量儿童体重和身高,采用Anthroplus测定BMI Z-score。此外,分别使用伊朗版儿童生活质量量表(PedsQLTM4.0)和抑郁、焦虑和压力量表(DASS-21)评估儿童的HRQoL和母亲的情绪状态。采用结构方程模型(SEM)评估母亲情绪状态与儿童BMI Z-score和HRQoL的直接和间接关系。结果:患儿平均年龄为13.8±3.1岁,BMI Z-score为0.74±1.5岁,HRQoL总分为84.7±11.3岁。在母亲中,抑郁、焦虑和压力三个量表的DASS-21得分中位数(四分位数范围)分别为4(0 - 10)、6(2 - 12)和14(8 - 20)。母亲受教育程度与DASS-21评分显著相关(β = -0.23, 95% CI: -0.37,-0.07)。母亲DASS-21评分仅在女孩中与BMI z评分显著相关(β = 0.25, 95% CI: 0.06, 0.53)。男孩HRQoL的显著决定因素是儿童年龄(β = -0.21, 95%CI: -0.40, -0.01)、母亲教育程度(β = -0.24, 95%CI: -0.44, -0.02)和情绪状态(β = -0.24, 95%CI: -0.44, -0.03)。儿童的年龄(β = -0.33, 95% CI: -0.53, -0.10)和母亲的情绪状态(β = -0.31, 95% CI: -0.54, -0.08)与女孩的HRQoL显著相关。结论:母亲情绪状态是影响儿童HRQoL的重要因素,与体重状况无关。建议进一步研究在农村和郊区人口中检验当前的假设模型,考虑更多的影响因素。
{"title":"Maternal Emotional States in Relation to Offspring Weight and Health-Related Quality of Life: Tehran Lipid and Glucose Study.","authors":"Parnian Parvin,&nbsp;Parisa Amiri,&nbsp;Sara Jalali-Farahani,&nbsp;Mehrdad Karimi,&nbsp;Mina Moein Eslam,&nbsp;Fereidoun Azizi","doi":"10.5812/ijem.113107","DOIUrl":"https://doi.org/10.5812/ijem.113107","url":null,"abstract":"<p><strong>Background: </strong>Maternal characteristics have been known to be associated with parenting practices, which could eventually influence their child's weight and health-related quality of life (HRQoL).</p><p><strong>Objectives: </strong>This study aimed to assess the direct and indirect associations of maternal emotional states (depression, anxiety, and stress) with body mass index (BMI) and HRQoL in their children.</p><p><strong>Methods: </strong>This study was conducted within the framework of the Tehran lipid and glucose study (TLGS). Participants were the children (n = 231) enrolled in TLGS during 2014 - 2016, who had complete data on maternal emotional states. The body weight and height of children were measured using the standard protocol, and BMI Z-score was determined using Anthroplus. Also, HRQoL in children and emotional states in mothers were assessed using the Iranian version of the pediatric quality of life inventory (PedsQLTM4.0) and the depression, anxiety, and stress scale (DASS-21), respectively. Structural equations modeling (SEM) was used to assess the direct and indirect relations of maternal emotional states with children's BMI Z-score and HRQoL.</p><p><strong>Results: </strong>Mean age, BMI Z-score, and HRQoL total score in children were 13.8 ± 3.1 years, 0.74 ± 1.5, and 84.7 ± 11.3, respectively. In the mothers, median DASS-21 scores (interquartile ranges) in the three scales of depression, anxiety, and stress were 4 (0 - 10), 6 (2 - 12), and 14 (8 - 20), respectively. Maternal level of education was significantly associated with the DASS-21 score (β = -0.23, 95% CI: -0.37,-0.07). Maternal DASS-21 score was significantly associated with BMI Z-score only in girls (β = 0.25, 95% CI: 0.06, 0.53). Significant determinants of HRQoL in boys were the child's age (β = -0.21, 95% CI: -0.40, -0.01) and maternal education (β = -0.24, 95%CI: -0.44, -0.02) and emotional state (β = -0.24, 95% CI: -0.44, -0.03). The child's age (β = -0.33, 95% CI: -0.53, -0.10) and maternal emotional state (β = -0.31, 95% CI: -0.54, -0.08) were significantly associated with HRQoL in girls.</p><p><strong>Conclusions: </strong>The maternal emotional state is an important determinant of HRQoL in children, regardless of their weight status. Further research is recommended to examine the current hypothesized model in rural and suburban populations, taking into consideration more influential factors.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f8/a7/ijem-19-4-113107.PMC8762283.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39962696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Anthropometric Indices and Age at Natural Menopause: A 15-Year Follow-up Population-Based Study. 人体测量指数与自然绝经年龄:一项为期15年的基于人群的随访研究。
IF 2.1 Q3 Medicine Pub Date : 2021-08-05 eCollection Date: 2021-10-01 DOI: 10.5812/ijem.109285
Maryam Farahmand, Fahimeh Ramezani Tehrani, Maryam Rahmati, Fereidoun Azizi

Background: Following menopause, the risk of many diseases is increased, and this situation may be due to changes in anthropometric indices (AI), while the association between adiposity and age at natural menopause (ANM) is not clear yet.

Objectives: This longitudinal study was conducted to investigate the ability of AI in predicting ANM.

Methods: For this purpose, a total of 3,876 women aged > 20 years old from participants of the Tehran lipid and glucose study (TLGS) met our eligibility criteria. The association between ANM and various AIs was assessed using the Accelerated Failure Time (AFT) model, and time ratio (TR) with 95% confidence intervals was reported in this longitudinal study.

Results: The median [interquartile range (IQR) 25 - 75] of the survival time was 12.5 (7.9 - 15.8) years. At the end of the follow-up, 1,479 (38.2%) of the participants reached menopause. The median time to natural menopause was decreased by about 2% with one standard deviation (SD) increase of both a body shape index (ABSI) (time ratio (TR): 0.98, 95% CI: 0.97, 0.99) and lipid accumulation product (LAP) (TR: 0.98, 95% CI: 0.98, 0.99) z-scores; and this time was increased by about 1% (TR: 1.01, 95% CI: 1.00, 1.02) with one SD increase in body mass index (BMI) z-score.

Conclusions: The ABSI, LAP, and BMI were the most useful AIs for identification of the time to menopause onset, and ABSI and LAP were inversely associated with the ANM. Also, the BMI was directly associated with the ANM.

背景:绝经后,许多疾病的风险增加,这种情况可能是由于人体测量指数(AI)的变化,而肥胖与自然绝经年龄(ANM)之间的关系尚不清楚。目的:本纵向研究旨在探讨人工智能预测ANM的能力。方法:为此,来自德黑兰脂质和葡萄糖研究(TLGS)参与者的3876名年龄> 20岁的女性符合我们的资格标准。使用加速失效时间(AFT)模型评估ANM与各种ai之间的关联,并在该纵向研究中报告了95%置信区间的时间比(TR)。结果:存活时间中位数[四分位间距(IQR) 25 ~ 75]为12.5(7.9 ~ 15.8)年。在随访结束时,1479名(38.2%)参与者进入更年期。到自然绝经的中位时间减少了约2%,体型指数(ABSI)(时间比(TR): 0.98, 95% CI: 0.97, 0.99)和脂质堆积产物(LAP) (TR: 0.98, 95% CI: 0.98, 0.99) z-得分均增加了一个标准差(SD);这次体重指数(BMI) z-score增加1个标准差,增加约1% (TR: 1.01, 95% CI: 1.00, 1.02)。结论:ABSI、LAP和BMI是确定绝经时间最有用的ai, ABSI和LAP与ANM呈负相关。此外,BMI与ANM直接相关。
{"title":"Anthropometric Indices and Age at Natural Menopause: A 15-Year Follow-up Population-Based Study.","authors":"Maryam Farahmand,&nbsp;Fahimeh Ramezani Tehrani,&nbsp;Maryam Rahmati,&nbsp;Fereidoun Azizi","doi":"10.5812/ijem.109285","DOIUrl":"https://doi.org/10.5812/ijem.109285","url":null,"abstract":"<p><strong>Background: </strong>Following menopause, the risk of many diseases is increased, and this situation may be due to changes in anthropometric indices (AI), while the association between adiposity and age at natural menopause (ANM) is not clear yet.</p><p><strong>Objectives: </strong>This longitudinal study was conducted to investigate the ability of AI in predicting ANM.</p><p><strong>Methods: </strong>For this purpose, a total of 3,876 women aged > 20 years old from participants of the Tehran lipid and glucose study (TLGS) met our eligibility criteria. The association between ANM and various AIs was assessed using the Accelerated Failure Time (AFT) model, and time ratio (TR) with 95% confidence intervals was reported in this longitudinal study.</p><p><strong>Results: </strong>The median [interquartile range (IQR) 25 - 75] of the survival time was 12.5 (7.9 - 15.8) years. At the end of the follow-up, 1,479 (38.2%) of the participants reached menopause. The median time to natural menopause was decreased by about 2% with one standard deviation (SD) increase of both a body shape index (ABSI) (time ratio (TR): 0.98, 95% CI: 0.97, 0.99) and lipid accumulation product (LAP) (TR: 0.98, 95% CI: 0.98, 0.99) z-scores; and this time was increased by about 1% (TR: 1.01, 95% CI: 1.00, 1.02) with one SD increase in body mass index (BMI) z-score.</p><p><strong>Conclusions: </strong>The ABSI, LAP, and BMI were the most useful AIs for identification of the time to menopause onset, and ABSI and LAP were inversely associated with the ANM. Also, the BMI was directly associated with the ANM.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c2/fc/ijem-19-4-109285.PMC8761485.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39920905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Scientific Publishing in Biomedicine: How to Write a Cover Letter? 生物医学科学出版:如何写求职信?
IF 2.1 Q3 Medicine Pub Date : 2021-07-25 eCollection Date: 2021-07-01 DOI: 10.5812/ijem.115242
Zahra Bahadoran, Parvin Mirmiran, Khosrow Kashfi, Asghar Ghasemi

A cover (covering) letter is a brief business letter introducing the scientific work alongside the submission process of a manuscript and is required by most scientific peer-review journals. A typical cover letter includes the name of the editor and the journal, date of submission, the characteristics of the manuscript, the importance of the work and its relevance to prospective audiences, declarations such as author agreements, conflicts of interest statement, funding source (s), and ethical statements. The letter also includes the contact information of the corresponding author (s) and may also include suggestions of potential reviewers. Spending enough time to draft an informative, comprehensive, and concise cover letter is quite worthwhile; a poorly drafted one would not persuade the editor that the submitted work is fit for publication and may lead to immediate rejection. Here, we provide a practical guide to draft a well-written, concise, and professional cover letter for a scientific medical paper.

cover letter(封面信)是一封简短的商业信函,介绍科学工作和手稿的提交过程,大多数科学同行评审期刊都要求。一封典型的求职信包括编辑和期刊的名称、提交日期、手稿的特征、工作的重要性及其对潜在读者的相关性、声明(如作者协议)、利益冲突声明、资金来源和道德声明。信中还包括通讯作者的联系方式,也可能包括潜在审稿人的建议。花足够的时间起草一份内容丰富、全面、简洁的求职信是非常值得的;一份草稿很差的稿子无法说服编辑认为提交的作品适合发表,而且可能会导致立即被拒稿。在这里,我们提供了一个实用的指南,为一篇科学医学论文起草一份写得好、简洁、专业的求职信。
{"title":"Scientific Publishing in Biomedicine: How to Write a Cover Letter?","authors":"Zahra Bahadoran,&nbsp;Parvin Mirmiran,&nbsp;Khosrow Kashfi,&nbsp;Asghar Ghasemi","doi":"10.5812/ijem.115242","DOIUrl":"https://doi.org/10.5812/ijem.115242","url":null,"abstract":"<p><p>A cover (covering) letter is a brief business letter introducing the scientific work alongside the submission process of a manuscript and is required by most scientific peer-review journals. A typical cover letter includes the name of the editor and the journal, date of submission, the characteristics of the manuscript, the importance of the work and its relevance to prospective audiences, declarations such as author agreements, conflicts of interest statement, funding source (s), and ethical statements. The letter also includes the contact information of the corresponding author (s) and may also include suggestions of potential reviewers. Spending enough time to draft an informative, comprehensive, and concise cover letter is quite worthwhile; a poorly drafted one would not persuade the editor that the submitted work is fit for publication and may lead to immediate rejection. Here, we provide a practical guide to draft a well-written, concise, and professional cover letter for a scientific medical paper.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e1/b0/ijem-19-3-115242.PMC8453652.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39474826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
A Clinical Debate: Subclinical Hypothyroidism. 临床辩论:亚临床甲减。
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2021-07-24 eCollection Date: 2021-07-01 DOI: 10.5812/ijem.115948
Sina Jasim, Hengameh Abdi, Hossein Gharib, Bernadette Biondi
{"title":"A Clinical Debate: Subclinical Hypothyroidism.","authors":"Sina Jasim, Hengameh Abdi, Hossein Gharib, Bernadette Biondi","doi":"10.5812/ijem.115948","DOIUrl":"10.5812/ijem.115948","url":null,"abstract":"","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/60/82/ijem-19-3-115948.PMC8453656.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39474830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Empowering Health Care Providers and Self-management Education in Diabetes? A Scoping Review. 授权医疗保健提供者和糖尿病自我管理教育?范围审查。
IF 2.1 Q3 Medicine Pub Date : 2021-07-19 eCollection Date: 2021-07-01 DOI: 10.5812/ijem.111765
Maryam Aalaa, Shahnaz Esmaeili, Hossein Yarmohammadi, Mahnaz Sanjari, Hossein Adibi, Ensieh Nasli-Esfahani

Context: There has been an increasing emphasis on the role of education in diabetes prevention and management, and shedding light on evidence gaps is mandatory for national action plans establishment.

Data sources: This scoping review was part of the Iranian Diabetes Road Map project that used a systematic method based on the Arksey and O'Malley approach.

Results: After the screening, 173 articles were included, most of which were published in 2018 and focused on self-management. Most included articles were considered patient-related self-management/care/efficacy, while only a limited number of articles studied healthcare provider education and educational establishment. Additionally, a significant number of included studies were addressed virtual education, an issue as the strength of Iranian studies in diabetes education.

Conclusions: Education is an important part of diabetes, and specific needs for Iranian patients should be addressed in future studies. Paying attention to new topics and conducting high-quality interventional studies will help fill evidence gaps in this field in Iran.

背景:人们越来越强调教育在糖尿病预防和管理中的作用,阐明证据差距是制定国家行动计划的必要条件。数据来源:这项范围审查是伊朗糖尿病路线图项目的一部分,该项目使用了基于Arksey和O'Malley方法的系统方法。结果:经筛选,共纳入173篇文献,其中大部分发表于2018年,以自我管理为主。大多数纳入的文章被认为是与患者相关的自我管理/护理/疗效,而只有有限数量的文章研究了医疗保健提供者教育和教育机构。此外,大量纳入的研究涉及虚拟教育,这是伊朗糖尿病教育研究的优势所在。结论:教育是糖尿病的重要组成部分,在未来的研究中应解决伊朗患者的特殊需求。关注新主题并开展高质量的干涉性研究将有助于填补伊朗这一领域的证据空白。
{"title":"Empowering Health Care Providers and Self-management Education in Diabetes? A Scoping Review.","authors":"Maryam Aalaa,&nbsp;Shahnaz Esmaeili,&nbsp;Hossein Yarmohammadi,&nbsp;Mahnaz Sanjari,&nbsp;Hossein Adibi,&nbsp;Ensieh Nasli-Esfahani","doi":"10.5812/ijem.111765","DOIUrl":"https://doi.org/10.5812/ijem.111765","url":null,"abstract":"<p><strong>Context: </strong>There has been an increasing emphasis on the role of education in diabetes prevention and management, and shedding light on evidence gaps is mandatory for national action plans establishment.</p><p><strong>Data sources: </strong>This scoping review was part of the Iranian Diabetes Road Map project that used a systematic method based on the Arksey and O'Malley approach.</p><p><strong>Results: </strong>After the screening, 173 articles were included, most of which were published in 2018 and focused on self-management. Most included articles were considered patient-related self-management/care/efficacy, while only a limited number of articles studied healthcare provider education and educational establishment. Additionally, a significant number of included studies were addressed virtual education, an issue as the strength of Iranian studies in diabetes education.</p><p><strong>Conclusions: </strong>Education is an important part of diabetes, and specific needs for Iranian patients should be addressed in future studies. Paying attention to new topics and conducting high-quality interventional studies will help fill evidence gaps in this field in Iran.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/97/bb/ijem-19-3-111765.PMC8453654.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39451550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
References and Citations: Is It Time to Update Their Format? 参考文献和引文:是时候更新格式了吗?
IF 2.1 Q3 Medicine Pub Date : 2021-07-13 eCollection Date: 2021-07-01 DOI: 10.5812/ijem.116404
Sai Krishna Gudi, Komal Krishna Tiwari, Rahamthulla Shaik
{"title":"References and Citations: Is It Time to Update Their Format?","authors":"Sai Krishna Gudi,&nbsp;Komal Krishna Tiwari,&nbsp;Rahamthulla Shaik","doi":"10.5812/ijem.116404","DOIUrl":"https://doi.org/10.5812/ijem.116404","url":null,"abstract":"<jats:p />","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a3/7a/ijem-19-3-116404.PMC8453648.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39474824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Associations Between Serum Concentrations of Irisin and Glucose-dependent Insulinotropic Polypeptide with Body Mass Index Among Women with and Without Polycystic Ovary Syndrome. 有或无多囊卵巢综合征妇女血清鸢尾素和葡萄糖依赖性胰岛素多肽浓度与体重指数的关系
IF 2.1 Q3 Medicine Pub Date : 2021-05-31 eCollection Date: 2021-10-01 DOI: 10.5812/ijem.111914
Samira Behboudi-Gandevani, Mehdi Hedayati, Mohammad Ali Mansournia, Maryam Nazemipour, Maryam Rahmati, Fahimeh Ramezani Tehrani

Background: The actions of adipocytokines may be a connective factor between obesity and polycystic ovary syndrome (PCOS). It is suggested that irisin, as recently described cytokine secreted by skeletal muscles and glucose-dependent insulinotropic polypeptide (GIP) as an incretin hormone that induces cytokine expression, may play key roles in favoring obesity in these women.

Objectives: We aimed to evaluate the association between body mass index (BMI) and serum concentrations of irisin/GIP in women with and without PCOS in the linear and non-linear models.

Methods: This cross-sectional study was conducted among 159 PCOS and 82 healthy eumenorrheic non-hirsute women aged 20 - 50 years. The fractional-polynomial model was used to develop a model of continuous risk factors, which evaluates non-linear associations between irisin/GIP and BMI among women with and without PCOS.

Results: Women with PCOS were significantly younger (28.2 ± 5.8 vs. 33.0 ± 7.8 years, P < 0.001) and had a greater BMI (26.6 ± 5.2 vs. 25.2 ± 4.8 kg/m2, P = 0.04) than the healthy counterparts. There were no significant linear and non-linear associations between serum concentration of irisin/GIP and BMI in both groups. The analysis of pair-wise age and BMI matching of women with PCOS and controls confirmed these findings.

Conclusions: This study showed that irisin and GIP have no association with BMI in women with or without PCOS. This finding could help to better understand the underlying pathophysiological status of PCOS, insulin resistance, and obesity-related disorders. Further large cohort studies are needed to confirm these findings.

背景:脂肪细胞因子的作用可能是肥胖与多囊卵巢综合征(PCOS)之间的关联因素。研究表明,鸢尾素作为骨骼肌分泌的细胞因子和葡萄糖依赖型胰岛素多肽(GIP)作为一种诱导细胞因子表达的肠促胰岛素激素,可能在这些女性的肥胖中起关键作用。目的:我们的目的是在线性和非线性模型中评估患有和不患有PCOS的女性体重指数(BMI)与血清中鸢尾素/GIP浓度之间的关系。方法:对159名多囊卵巢综合征女性和82名20 ~ 50岁健康无多毛绝经期女性进行横断面研究。采用分数-多项式模型建立连续危险因素模型,评估有PCOS和无PCOS女性中鸢尾素/GIP与BMI之间的非线性关联。结果:PCOS女性明显比健康女性年轻(28.2±5.8岁比33.0±7.8岁,P < 0.001), BMI高于健康女性(26.6±5.2比25.2±4.8 kg/m2, P = 0.04)。两组患者血清中鸢尾素/GIP浓度与BMI之间均无显著的线性和非线性关联。对多囊卵巢综合征女性和对照组的年龄和BMI配对分析证实了这些发现。结论:本研究表明,鸢尾素和GIP与患有或不患有PCOS的女性的BMI无关。这一发现有助于更好地了解多囊卵巢综合征、胰岛素抵抗和肥胖相关疾病的潜在病理生理状态。需要进一步的大型队列研究来证实这些发现。
{"title":"The Associations Between Serum Concentrations of Irisin and Glucose-dependent Insulinotropic Polypeptide with Body Mass Index Among Women with and Without Polycystic Ovary Syndrome.","authors":"Samira Behboudi-Gandevani,&nbsp;Mehdi Hedayati,&nbsp;Mohammad Ali Mansournia,&nbsp;Maryam Nazemipour,&nbsp;Maryam Rahmati,&nbsp;Fahimeh Ramezani Tehrani","doi":"10.5812/ijem.111914","DOIUrl":"https://doi.org/10.5812/ijem.111914","url":null,"abstract":"<p><strong>Background: </strong>The actions of adipocytokines may be a connective factor between obesity and polycystic ovary syndrome (PCOS). It is suggested that irisin, as recently described cytokine secreted by skeletal muscles and glucose-dependent insulinotropic polypeptide (GIP) as an incretin hormone that induces cytokine expression, may play key roles in favoring obesity in these women.</p><p><strong>Objectives: </strong>We aimed to evaluate the association between body mass index (BMI) and serum concentrations of irisin/GIP in women with and without PCOS in the linear and non-linear models.</p><p><strong>Methods: </strong>This cross-sectional study was conducted among 159 PCOS and 82 healthy eumenorrheic non-hirsute women aged 20 - 50 years. The fractional-polynomial model was used to develop a model of continuous risk factors, which evaluates non-linear associations between irisin/GIP and BMI among women with and without PCOS.</p><p><strong>Results: </strong>Women with PCOS were significantly younger (28.2 ± 5.8 vs. 33.0 ± 7.8 years, P < 0.001) and had a greater BMI (26.6 ± 5.2 vs. 25.2 ± 4.8 kg/m<sup>2</sup>, P = 0.04) than the healthy counterparts. There were no significant linear and non-linear associations between serum concentration of irisin/GIP and BMI in both groups. The analysis of pair-wise age and BMI matching of women with PCOS and controls confirmed these findings.</p><p><strong>Conclusions: </strong>This study showed that irisin and GIP have no association with BMI in women with or without PCOS. This finding could help to better understand the underlying pathophysiological status of PCOS, insulin resistance, and obesity-related disorders. Further large cohort studies are needed to confirm these findings.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/88/40/ijem-19-4-111914.PMC8761486.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39920906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case Report of ROHHAD Syndrome in an 8-year-old Iranian Boy. 伊朗8岁男童ROHHAD综合征1例报告。
IF 2.1 Q3 Medicine Pub Date : 2021-05-22 eCollection Date: 2021-07-01 DOI: 10.5812/ijem.111571
Abolfazl Amjadipour, Lobat Shahkar, Faridreza Hanafi

Introduction: Rapid-onset obesity concurrently with hypoventilation, hypothalamic, autonomic dysregulation (ROHHAD) is an uncommon disease that presents with multiorgan disorders during early childhood, with fewer than 100 cases reported around the world. We aim to present a case of ROHHAD syndrome admitting with rare neurologic symptoms. We also present our treatment regimen.

Case presentation: An 8-year-old boy was admitted to our department with ataxia and gait disturbance that led us to the final diagnosis after a thorough investigation. He had multiple admissions and was treated for other diagnoses. His first symptoms started from age 5 with obstructive apnea. He underwent an adenectomy surgery at that time, but the symptoms continued. A year after the surgery, he was admitted again due to his somnolence but was diagnosed only with hypothyroidism and anemia. At the age of 7 years and 8 months, he was admitted to our department with ataxia and abnormal gait from the past year with instability and numerous falls. He also had shown hyperphagia that had been resulted in 10 kilograms of weight gain in six months. He was experiencing gradual behavioral symptoms, including episodes of self and hetero aggression and impulsivity. His other symptoms included fatigue, somnolence, gastrointestinal dysmotility, hyperhidrosis, central hypothyroidism, polyuria, precocious puberty, and rapid obesity. His laboratory investigation revealed hyperprolactinemia.

Conclusions: Our case indicates that ROHHAD is a complex disease with divergent signs and symptoms that needs to be kept in mind for diagnosis and should be treated with a high level of collaboration of various medical specialties. Since late diagnosis of this syndrome leads to a magnificent increase in morbidity and mortality rates, it is vital to pay extreme attention to this syndrome. The diagnosis should be considered even more in children over two years old with rapid-onset obesity, which is accompanied by other symptoms. Here, our patient's complaint was ataxia that revealed the underlying cause after investigation.

快速发作性肥胖并发低通气、下丘脑、自主神经失调(ROHHAD)是一种罕见的疾病,在儿童早期表现为多器官疾病,世界范围内报道的病例不到100例。我们的目的是提出一个病例ROHHAD综合征承认与罕见的神经系统症状。我们还介绍了我们的治疗方案。病例介绍:一名8岁男孩因共济失调和步态障碍入院,经过彻底的调查后,我们对其进行了最终诊断。他多次入院,并接受了其他诊断的治疗。他的第一个症状始于5岁患有阻塞性呼吸暂停他当时接受了腺切除手术,但症状仍在继续。手术一年后,他再次因嗜睡而入院,但被诊断为甲状腺功能减退和贫血。在7岁零8个月时,他因过去一年的共济失调和步态异常而入院,伴有不稳定和多次跌倒。他还表现出贪食症,在6个月内体重增加了10公斤。他正在经历逐渐的行为症状,包括自我和异性攻击和冲动的发作。他的其他症状包括疲劳、嗜睡、胃肠运动障碍、多汗症、中枢性甲状腺功能减退、多尿、性早熟和快速肥胖。他的实验室检查显示高泌乳素血症。结论:本病例提示ROHHAD是一种体征和症状多样的复杂疾病,在诊断时应牢记于心,应在各医学专业的高度合作下治疗。由于这一综合征的晚期诊断导致发病率和死亡率的大幅增加,因此对这一综合征给予高度重视至关重要。对于两岁以上伴有其他症状的速发性肥胖儿童,更应考虑诊断。在这里,我们的病人的主诉是共济失调,在调查后发现了潜在的原因。
{"title":"A Case Report of ROHHAD Syndrome in an 8-year-old Iranian Boy.","authors":"Abolfazl Amjadipour,&nbsp;Lobat Shahkar,&nbsp;Faridreza Hanafi","doi":"10.5812/ijem.111571","DOIUrl":"https://doi.org/10.5812/ijem.111571","url":null,"abstract":"<p><strong>Introduction: </strong>Rapid-onset obesity concurrently with hypoventilation, hypothalamic, autonomic dysregulation (ROHHAD) is an uncommon disease that presents with multiorgan disorders during early childhood, with fewer than 100 cases reported around the world. We aim to present a case of ROHHAD syndrome admitting with rare neurologic symptoms. We also present our treatment regimen.</p><p><strong>Case presentation: </strong>An 8-year-old boy was admitted to our department with ataxia and gait disturbance that led us to the final diagnosis after a thorough investigation. He had multiple admissions and was treated for other diagnoses. His first symptoms started from age 5 with obstructive apnea. He underwent an adenectomy surgery at that time, but the symptoms continued. A year after the surgery, he was admitted again due to his somnolence but was diagnosed only with hypothyroidism and anemia. At the age of 7 years and 8 months, he was admitted to our department with ataxia and abnormal gait from the past year with instability and numerous falls. He also had shown hyperphagia that had been resulted in 10 kilograms of weight gain in six months. He was experiencing gradual behavioral symptoms, including episodes of self and hetero aggression and impulsivity. His other symptoms included fatigue, somnolence, gastrointestinal dysmotility, hyperhidrosis, central hypothyroidism, polyuria, precocious puberty, and rapid obesity. His laboratory investigation revealed hyperprolactinemia.</p><p><strong>Conclusions: </strong>Our case indicates that ROHHAD is a complex disease with divergent signs and symptoms that needs to be kept in mind for diagnosis and should be treated with a high level of collaboration of various medical specialties. Since late diagnosis of this syndrome leads to a magnificent increase in morbidity and mortality rates, it is vital to pay extreme attention to this syndrome. The diagnosis should be considered even more in children over two years old with rapid-onset obesity, which is accompanied by other symptoms. Here, our patient's complaint was ataxia that revealed the underlying cause after investigation.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4e/a5/ijem-19-3-111571.PMC8453650.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39451549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Longer Time to Reach Excellent Response to Treatment in Familial Versus Sporadic Non-medullary Thyroid Cancer (NMTC): A Matched Case-Control Study. 家族性与散发性非髓样甲状腺癌(NMTC)较长时间达到良好的治疗反应:一项匹配的病例对照研究
IF 2.1 Q3 Medicine Pub Date : 2021-05-11 eCollection Date: 2021-04-01 DOI: 10.5812/ijem.108781
Susan Shafiei, Mehrdokht Sadrolodabaei, Atena Aghaei, Narjess Ayati, Samira Zare Namdar, Donya Hemati, Seyed Rasoul Zakavi

Background: Familial non-medullary thyroid cancer (NMTC) are supposed to be more aggressive and require more frequent treatment compared to non-familial thyroid cancer.

Objectives: This matched case-control study aimed to compare the response to treatment between the matched case-control groups of familial and sporadic NMTC.

Methods: This is a retrospective study in patients with familial NMTC (at least one other first-degree relative involved) who were treated with surgery, followed by radio-iodine therapy (RIT) without consideration of its familial origin. Response to treatment was compared between familial NMTC and age, sex, and TNM stage-matched non-familial NMTC (control group). Response to treatment was assessed one and two years after RIT, and time to excellent response was identified.

Results: Out of 2,944 NMTC patients, 81 (2.75%) patients had familial NMTC. We compared 66 patients with familial NMTC and 66 sporadic NMTC patients. There was no significant difference in first thyroglobulin, initial and accumulative iodine dose, and additional treatments (additional surgery and radiotherapy) between patients and controls. Although no significant difference was noted in one and two years' responses to treatment between the case and control groups, familial NMTC patients required more time to achieve excellent response (26.7 ± 24.9 versus 15.9 ± 9.0 months, P = 0.01). No significant difference was noted between familial NMTC patients with two or more than two involved relatives.

Conclusions: Our study showed that if patients with familial NMTCs were treated in the same way as non-familial patients, the time to excellent response would be significantly longer, even when they have only one other involved relative.

背景:家族性非髓样甲状腺癌(NMTC)被认为比非家族性甲状腺癌更具侵袭性,需要更频繁的治疗。目的:本配对病例对照研究旨在比较家族性和散发性NMTC配对病例对照组之间的治疗反应。方法:这是一项回顾性研究,对家族性NMTC患者(至少有一个其他一级亲属参与)进行手术治疗,然后进行放射性碘治疗(RIT),而不考虑其家族起源。比较家族性NMTC与年龄、性别和TNM分期匹配的非家族性NMTC(对照组)对治疗的反应。RIT后1年和2年评估对治疗的反应,并确定达到良好反应的时间。结果:2944例NMTC患者中,81例(2.75%)为家族性NMTC。我们比较了66例家族性NMTC和66例散发性NMTC患者。患者和对照组在首次甲状腺球蛋白、初始和累积碘剂量以及附加治疗(附加手术和放疗)方面无显著差异。尽管病例组和对照组在1年和2年的治疗反应上没有显著差异,但家族性NMTC患者需要更多的时间才能达到优异的疗效(26.7±24.9个月比15.9±9.0个月,P = 0.01)。有两个或两个以上亲属的家族性NMTC患者之间无显著差异。结论:我们的研究表明,如果家族性NMTCs患者与非家族性NMTCs患者采用相同的治疗方法,即使他们只有一个其他相关亲属,获得良好反应的时间也会明显更长。
{"title":"Longer Time to Reach Excellent Response to Treatment in Familial Versus Sporadic Non-medullary Thyroid Cancer (NMTC): A Matched Case-Control Study.","authors":"Susan Shafiei,&nbsp;Mehrdokht Sadrolodabaei,&nbsp;Atena Aghaei,&nbsp;Narjess Ayati,&nbsp;Samira Zare Namdar,&nbsp;Donya Hemati,&nbsp;Seyed Rasoul Zakavi","doi":"10.5812/ijem.108781","DOIUrl":"https://doi.org/10.5812/ijem.108781","url":null,"abstract":"<p><strong>Background: </strong>Familial non-medullary thyroid cancer (NMTC) are supposed to be more aggressive and require more frequent treatment compared to non-familial thyroid cancer.</p><p><strong>Objectives: </strong>This matched case-control study aimed to compare the response to treatment between the matched case-control groups of familial and sporadic NMTC.</p><p><strong>Methods: </strong>This is a retrospective study in patients with familial NMTC (at least one other first-degree relative involved) who were treated with surgery, followed by radio-iodine therapy (RIT) without consideration of its familial origin. Response to treatment was compared between familial NMTC and age, sex, and TNM stage-matched non-familial NMTC (control group). Response to treatment was assessed one and two years after RIT, and time to excellent response was identified.</p><p><strong>Results: </strong>Out of 2,944 NMTC patients, 81 (2.75%) patients had familial NMTC. We compared 66 patients with familial NMTC and 66 sporadic NMTC patients. There was no significant difference in first thyroglobulin, initial and accumulative iodine dose, and additional treatments (additional surgery and radiotherapy) between patients and controls. Although no significant difference was noted in one and two years' responses to treatment between the case and control groups, familial NMTC patients required more time to achieve excellent response (26.7 ± 24.9 versus 15.9 ± 9.0 months, P = 0.01). No significant difference was noted between familial NMTC patients with two or more than two involved relatives.</p><p><strong>Conclusions: </strong>Our study showed that if patients with familial NMTCs were treated in the same way as non-familial patients, the time to excellent response would be significantly longer, even when they have only one other involved relative.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2021-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a2/5c/ijem-19-2-108781.PMC8198615.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39249534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Endocrinology and Metabolism
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1